IG Confirms Many Recovery Act Criminal Investigations
Client Alert | less than 1 min read | 11.03.11
In what should serve as a warning that use of Recovery Act funds continues to draw close scrutiny from federal watchdogs, in written testimony on November 2 before a House subcommittee, DoE Inspector General Friedman revealed that his office has initiated over 100 criminal investigations involving “various schemes, including the submission of false information [and] claims for unallowable or unauthorized expenses,” under the Recovery Act. He also confirmed that his office has “ongoing and planned reviews” of Recovery Act funding and usage.
Contacts
Insights
Client Alert | 6 min read | 09.03.26
FDA Seeks Input for Regulating GenAI-Powered Medical Devices
The U.S. Food & Drug Administration (FDA) is seeking feedback on a regulatory framework that could be used to evaluate generative artificial intelligence (GenAI)-enabled medical devices. Such devices could create new types of risks because their outputs can vary and evolve, unlike more traditional software-enabled devices. An August 18, 2026, discussion paper (“Considerations for the regulation of GenAI-enabled medical devices”) discusses potential regulatory considerations for GenAI-enabled medical devices.
Client Alert | less than 1 min read | 09.03.26
SBA Proposal to Overhaul Size Standards Would Transform Federal Government Contracting
Client Alert | 5 min read | 09.02.26
DOJ’s Civil Rights Fraud Initiative Claims Another DEI-Related FCA Settlement
Client Alert | 4 min read | 09.02.26
